FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313530109> ?p ?o ?g. }

• W4313530109 endingPage "30" @default.
• W4313530109 startingPage "17" @default.
• W4313530109 abstract "Whether an antidiabetic drug, glucagon-like peptide-1 receptor agonist (GLP-1RA), could improve the prognosis of heart failure and cardiac function remains controversial. We conducted a systematic review and meta-analysis of randomized controlled trials to explore the influence of GLP-1RAs on heart failure in patients regardless of diabetes diagnosis.Literature in English from the PubMed, EMBASE, and Cochrane Library databases was searched from inception to July 2022. The study aim was to identify published, randomized, placebo-controlled trials testing GLP-1RAs in patients with or without diabetes. Outcomes were heart failure hospitalization, cardiac function, and structure measures.Twenty-two randomized controlled trials involving 61,412 patients are included in the meta-analysis. Overall, compared with the placebo group, GLP-1RA treatment could not significantly decrease heart failure hospitalization in patients with a history of heart failure (hazard ratio [HR], 1.07; 95% CI, 0.91 to 1.25; P = 0.422). Six-minute walking test distances (WMD, 19.08 m; 95% CI, 4.81 to 33.36; P = 0.01), E-wave (SMD, -0.40; 95% CI, -0.60 to -0.20; P < 0.001), early diastolic to late diastolic velocities ratio (WMD, -0.10; 95% CI, -0.18 to -0.02; P = 0.01), mitral inflow E velocity to tissue Doppler e' ratio (WMD, -0.97; 95% CI, -1.54 to -0.41; P < 0.001), and E-wave deceleration time (WMD, -9.96 milliseconds; 95% CI, -18.52 to -1.41; P = 0.02) increased significantly after administration of GLP-1RAs. However, GLP-1RAs do not significantly influence N-terminal pro-B-type natriuretic peptide levels (WMD, -20.02 pg/mL; 95% CI, -53.12 to 13.08; P = 0.24), Minnesota Living with Heart Failure Questionnaire quality of life scores (WMD, -1.08; 95% CI, -3.99 to 1.84; P = 0.47), or left ventricular ejection fractions (WMD, -0.37%; 95% CI, -1.19 to 0.46; P = 0.38).GLP-1RAs did not reduce heart failure readmissions in patients with a history of heart failure and elevated N-terminal pro-B-type natriuretic peptide levels. Thus, the prognosis of heart failure was not improved, although GLP-1RAs did significantly improve left ventricular diastolic function in patients. PROSPERO identifier: CRD42021226231." @default.
• W4313530109 created "2023-01-06" @default.
• W4313530109 creator A5006175809 @default.
• W4313530109 creator A5075854261 @default.
• W4313530109 creator A5084387510 @default.
• W4313530109 date "2023-01-01" @default.
• W4313530109 modified "2023-10-18" @default.
• W4313530109 title "Effect of Glucagon-like Peptide-1 Receptor Agonists on Prognosis of Heart Failure and Cardiac Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials" @default.
• W4313530109 cites W2019566854 @default.
• W4313530109 cites W2032322539 @default.
• W4313530109 cites W2051298109 @default.
• W4313530109 cites W2063400466 @default.
• W4313530109 cites W2148850438 @default.
• W4313530109 cites W2149802883 @default.
• W4313530109 cites W2150913805 @default.
• W4313530109 cites W2176988096 @default.
• W4313530109 cites W2282578582 @default.
• W4313530109 cites W2335779504 @default.
• W4313530109 cites W2425644022 @default.
• W4313530109 cites W2463716829 @default.
• W4313530109 cites W2486862036 @default.
• W4313530109 cites W2505843168 @default.
• W4313530109 cites W2519510391 @default.
• W4313530109 cites W2529813822 @default.
• W4313530109 cites W2542456927 @default.
• W4313530109 cites W2586303576 @default.
• W4313530109 cites W2624103593 @default.
• W4313530109 cites W2721084895 @default.
• W4313530109 cites W2754041380 @default.
• W4313530109 cites W2792000280 @default.
• W4313530109 cites W2891135391 @default.
• W4313530109 cites W2894746763 @default.
• W4313530109 cites W2908065012 @default.
• W4313530109 cites W2936593438 @default.
• W4313530109 cites W2941506137 @default.
• W4313530109 cites W2946264273 @default.
• W4313530109 cites W2948612418 @default.
• W4313530109 cites W2965236780 @default.
• W4313530109 cites W2985002379 @default.
• W4313530109 cites W2992821646 @default.
• W4313530109 cites W3003238214 @default.
• W4313530109 cites W3007777985 @default.
• W4313530109 cites W3008930226 @default.
• W4313530109 cites W3009912045 @default.
• W4313530109 cites W3022903699 @default.
• W4313530109 cites W3023916492 @default.
• W4313530109 cites W3036846551 @default.
• W4313530109 cites W3082464276 @default.
• W4313530109 cites W3083723931 @default.
• W4313530109 cites W3093433501 @default.
• W4313530109 cites W3130013319 @default.
• W4313530109 cites W3177365549 @default.
• W4313530109 cites W3200446817 @default.
• W4313530109 cites W4206445899 @default.
• W4313530109 cites W4220656413 @default.
• W4313530109 doi "https://doi.org/10.1016/j.clinthera.2022.12.006" @default.
• W4313530109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36604209" @default.
• W4313530109 hasPublicationYear "2023" @default.
• W4313530109 type Work @default.
• W4313530109 citedByCount "2" @default.
• W4313530109 countsByYear W43135301092023 @default.
• W4313530109 crossrefType "journal-article" @default.
• W4313530109 hasAuthorship W4313530109A5006175809 @default.
• W4313530109 hasAuthorship W4313530109A5075854261 @default.
• W4313530109 hasAuthorship W4313530109A5084387510 @default.
• W4313530109 hasBestOaLocation W43135301091 @default.
• W4313530109 hasConcept C111566952 @default.
• W4313530109 hasConcept C126322002 @default.
• W4313530109 hasConcept C134018914 @default.
• W4313530109 hasConcept C142724271 @default.
• W4313530109 hasConcept C164705383 @default.
• W4313530109 hasConcept C168563851 @default.
• W4313530109 hasConcept C204787440 @default.
• W4313530109 hasConcept C207103383 @default.
• W4313530109 hasConcept C27081682 @default.
• W4313530109 hasConcept C2776478404 @default.
• W4313530109 hasConcept C2778198053 @default.
• W4313530109 hasConcept C2778789114 @default.
• W4313530109 hasConcept C44249647 @default.
• W4313530109 hasConcept C555293320 @default.
• W4313530109 hasConcept C71924100 @default.
• W4313530109 hasConcept C95190672 @default.
• W4313530109 hasConceptScore W4313530109C111566952 @default.
• W4313530109 hasConceptScore W4313530109C126322002 @default.
• W4313530109 hasConceptScore W4313530109C134018914 @default.
• W4313530109 hasConceptScore W4313530109C142724271 @default.
• W4313530109 hasConceptScore W4313530109C164705383 @default.
• W4313530109 hasConceptScore W4313530109C168563851 @default.
• W4313530109 hasConceptScore W4313530109C204787440 @default.
• W4313530109 hasConceptScore W4313530109C207103383 @default.
• W4313530109 hasConceptScore W4313530109C27081682 @default.
• W4313530109 hasConceptScore W4313530109C2776478404 @default.
• W4313530109 hasConceptScore W4313530109C2778198053 @default.
• W4313530109 hasConceptScore W4313530109C2778789114 @default.
• W4313530109 hasConceptScore W4313530109C44249647 @default.
• W4313530109 hasConceptScore W4313530109C555293320 @default.
• W4313530109 hasConceptScore W4313530109C71924100 @default.
• W4313530109 hasConceptScore W4313530109C95190672 @default.

• next